MYCN and neuroblastoma: Targeting key enzymes involved in metabolic pathways, such as ornithine decarboxylase (ODC), which catalyzes the rate limiting step on polyamine biosynthesis, and hexokinase (the first step on glycolysis), which not only induces neuroblastoma cell death, but also reduces MYCN protein levels [135,225].